Net profit of Supriya Lifescience rose 56.58% to Rs 44.64 crore in the quarter ended June 2024 as against Rs 28.51 crore during the previous quarter ended June 2023. Sales rose 21.67% to Rs 160.63 crore in the quarter ended June 2024 as against Rs 132.02 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 160.63 | 132.02 | 22 |
| OPM % | 38.94 | 33.50 | - |
| PBDT | 64.43 | 46.59 | 38 |
| PBT | 59.77 | 42.63 | 40 |
| NP | 44.64 | 28.51 | 57 |